Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations

被引:0
|
作者
Roukos, Dimitrios H. [1 ]
机构
[1] Univ Ioannina, GR-45110 Ioannina, Greece
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 357卷 / 15期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1555 / 1556
页数:2
相关论文
共 50 条
  • [21] Comparing prognosis for BRCA1, BRCA2 and non-BRCA breast cancer
    Meireles, Pedro Antunes
    Bexiga, Catarina
    Fragoso, Sofia
    Santos, Sidonia
    Duarte, Teresa
    Vaz, Fatima
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [22] Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer
    Antunes Meireles, Pedro
    Fragoso, Sofia
    Duarte, Teresa
    Santos, Sidonia
    Bexiga, Catarina
    Nejo, Priscila
    Luis, Ana
    Mira, Beatriz
    Miguel, Isalia
    Rodrigues, Paula
    Vaz, Fatima
    [J]. CANCERS, 2023, 15 (23)
  • [23] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [24] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    [J]. MODERN PATHOLOGY, 2019, 32
  • [25] Immunophenotypic characterization of breast cancers in carriers of BRCA1/BRCA2 mutations.
    Simon, SD
    Bacchi, CE
    Molina, AL
    Moreira-Filho, CA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 870S - 870S
  • [26] Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2:: Are they prognostically different?
    Phillips, KA
    Andrulis, IL
    Goodwin, PJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3653 - 3663
  • [27] Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
    De Talhouet, Solene
    Peron, Julien
    Vuilleumier, Aurelie
    Friedlaender, Alex
    Viassolo, Valeria
    Ayme, Aurelie
    Bodmer, Alexandre
    Treilleux, Isabelle
    Lang, Noemie
    Tille, Jean- Christophe
    Chappuis, Pierre O.
    Buisson, Adrien
    Giraud, Sophie
    Lasset, Christine
    Bonadona, Valerie
    Tredan, Olivier
    Labidi-Galy, S. Intidhar
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
    Solene De Talhouet
    Julien Peron
    Aurelie Vuilleumier
    Alex Friedlaender
    Valeria Viassolo
    Aurélie Ayme
    Alexandre Bodmer
    Isabelle Treilleux
    Noemie Lang
    Jean- Christophe Tille
    Pierre O. Chappuis
    Adrien Buisson
    Sophie Giraud
    Christine Lasset
    Valerie Bonadona
    Olivier Trédan
    S.Intidhar Labidi-Galy
    [J]. Scientific Reports, 10
  • [29] Aspirin and breast cancer risk for BRCA1 and BRCA2 mutation carriers
    Kornhauser, Naomi
    Terry, Mary Beth
    Vahdat, Linda T.
    Andrulis, Irene
    Buys, Saundra
    Daly, Mary
    John, Esther
    Hopper, John L.
    Cigler, Tessa
    [J]. CANCER RESEARCH, 2015, 75
  • [30] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    K Metcalfe
    S Gershman
    H T Lynch
    P Ghadirian
    N Tung
    C Kim-Sing
    O I Olopade
    S Domchek
    J McLennan
    A Eisen
    W D Foulkes
    B Rosen
    P Sun
    S A Narod
    [J]. British Journal of Cancer, 2011, 104 : 1384 - 1392